15 Biggest Mid-Day Losers For Monday

Root9B Holdings Inc RTNB shares tumbled 24.9 percent to $1.60.
Zynerba Pharmaceuticals Inc ZYNE shares dipped 20.5 percent to $5.59 after the company disclosed that its Phase 2 STOP trial did not meet its primary endpoint. However, the company trial did meet some secondary endpoints.
Sorl Auto Parts, Inc. SORL shares dropped 18.7 percent to $5.67 after the company reported weak Q2 results.
Energy XXI Gulf Coast Inc EXXI shares fell 13.6 percent to $14.77. On Friday, Energy XXI Gulf Coast reported a Q2 net loss of $23.6 million or $0.71 loss per share.
Akoustis Technologies Inc AKTS shares declined 12.5 percent to $5.33.
XCel Brands Inc XELB shares fell 11.5 percent to $3.81.
Apollo Endosurgery Inc APEN shares tumbled 11.5 percent to $3.99.
DarioHealth Corp DRIO shares fell 9.3 percent to $2.11. DarioHealth posted Q2 loss of $0.43 per share on sales of $1.21 million.
Repros Therapeutics Inc RPRX dropped 8.6 percent to $0.320. Repros Therapeutics reported a Q2 loss of $0.08 per share on sales of $7,000.
Eleven Biotherapeutics Inc EBIO shares declined 8.2 percent to $1.33. Eleven Biotherapeutics reported a Q2 loss of $0.30 per share.
Canadian Solar Inc. CSIQ dropped 5.5 percent to $16.26. Canadian Solar reported Q2 earnings of $38.2 million.
Nabors Industries Ltd. NBR declined 4.6 percent to $6.49 as the company announced an agreement to acquire Tesco in an all-stock transaction valued at $4.62 per share.
JD.Com Inc(ADR) JD fell 4.2 percent to $44.01 after the company posted a wider net loss for the second quarter. The company’s net loss attributable to shareholders widened to 496.4 million yuan ($74.43 million), versus 252.3 million yuan in the year-ago period.
Companhia de Saneamento Basico (ADR) SBS shares declined 3.8 percent to $10.02. Citigroup downgraded Companhia de saneamento Basico from Neutral to Sell.
LiqTech International Inc LIQT dropped 3.6 percent to $0.338. LiqTech International reported a Q2 loss of $0.03 per share on sales of $2.9 million.

Market News and Data brought to you by Benzinga APIs

Comments

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga